Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person imidaprilat [endoplasmic reticulum lumen]

Class:Id	ChemicalDrug:9619026
_displayName	imidaprilat [endoplasmic reticulum lumen]
_timestamp	2018-12-12 00:29:45
compartment	[Compartment:17957] endoplasmic reticulum lumen
created	[InstanceEdit:9619045] Jassal, Bijay, 2018-09-14
crossReference	[DatabaseIdentifier:9628097] ChEBI:141520
disease	[Disease:9608426] hypertension [Disease:9611005] myocardial infarction
literatureReference	[LiteratureReference:9615093] A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring [LiteratureReference:9615171] Imidapril in heart failure [LiteratureReference:9615185] Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure
modified	[InstanceEdit:9625668] Jassal, Bijay, 2018-10-22 [InstanceEdit:9627975] Wu, G, 2018-11-05 [InstanceEdit:9631716] Wu, G, 2018-12-12
name	imidaprilat
referenceEntity	[ReferenceTherapeutic:9614955] imidaprilat [Guide to Pharmacology:6378]
stableIdentifier	[StableIdentifier:9619066] R-ALL-9619026.2
(hasMember)	[DefinedSet:9619021] hydrolysed ACEIs [endoplasmic reticulum lumen]
[Change default viewing format]

No pathways have been reviewed or authored by imidaprilat [endoplasmic reticulum lumen] (9619026)